TABLE 6.
In vivo bacterial effects in presence of catecholamines.
| Bacterial species | Catecholamines (dose) | In vivo effects | Antagonists | References |
| Aeromonas hydrophyla | NE (1 mg/400 μL) | NE enhances the systemic spread of the bacteria during infection of mice | n. | Dong et al., 2016 |
| NE (100 μM) | Increased mortality of crucian carp | n. | Gao et al., 2019 | |
| Pseudomonas aeruginosa H103 | Epi (1–10 μM) | Increased mortality of Galleria mellonella larvae (with 10 μM Epi) | n. | Cambronel et al., 2019 |
| Salmonella enterica serovar Typhimurium | NE (200 mg/kg) | Oral administration of NE, but not preculture with NE alters the course of infection in pigs | n. | Pullinger et al., 2010 |
| Vibrio campbelli BB120 | NE/Dopamine (100 μM) | Increased virulence toward giant freshwater prawn larvae (Macrobrachium rosenbergii) | Phentolamine Chlorpromazine | Pande et al., 2014 |
| Vibrio harveyi | NE/Dopamine (50 μM) | Increased virulence toward gnotobiotic brine shrimp larvae | Phentolamine Phenoxybenzamine Labetalol LED209 Chlorpromazine | Yang Q. et al., 2014 |
| Yersinia ruckeri | NE/Dopamine (100 μM) | Increased mortality of rainbow trout | Phenoxybenzamine Labetalol Propanolol Chlorpromazine | Torabi Delshad et al., 2019 |
n, not used in the study.